Terapi Inhalasi Nebulizer Vs MDI Spacer Sebagai Terapi Asma Akut pada Anak di Rumah

Oleh :

dr. Ferdinand Sukher

Terapi inhalasi dengan metode nebulizer dan metered dose inhaler (MDI) spacer untuk terapi asma akut pada anak di rumah memberikan efek bronkodilator langsung ke target organ dengan efek samping sistemik yang minimal. Akan tetapi, masih terdapat perdebatan mengenai keuntungan penggunaan nebulizer dibandingkan dengan MDI spacer untuk penggunaan di rumah baik oleh pasien maupun orang tua pasien.[1, 2]

Saat terjadi serangan asma, saluran napas menjadi sempit karena bronkokonstriksi, edema, dan peningkatan produksi sekret, sehingga anak mengalami kesulitan bernapas. Terapi inisial untuk serangan asma adalah terapi inhalasi dengan short acting beta agonist (SABA) untuk membuka jalan napas agar pasien dapat kembali bernapas dengan adekuat.[1,2]

Kelebihan dan Kekurangan Terapi Inhalasi

(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)

Referensi

1. GINA committee. Global Strategy for Asthma Management and Prevention 2022 Update. Global Initiative for Asthma 2022; 225.
2. Supriyatno B, Kartasasmita CB, Setyanto DB, et al. Terapi Inhalasi pada Anak. IDAI, https://pediatricfkuns.ac.id/data/ebook/Buku-Rekomendasi-Terapi-Inhalasi-new.pdf (2019).
3. Than K, Grobelna A. Medication Administration With Inhalers or Nebulizers. Can J Heal Technol 2021; 1: 1–34.
4. Martin J, Townshend J, Brodlie M. Diagnosis and management of asthma in children. BMJ Paediatr Open 2022; 6: 1–12.
5. Pleasants RA, Hess DR. Aerosol delivery devices for obstructive lung diseases. Respir Care 2018; 63: 708–733.
6. Ari A, Fink JB. Recent advances in aerosol devices for the delivery of inhaled medications. Expert Opin Drug Deliv 2020; 17: 133–144.
7. Abaya R, Delgado EM, Scarfone RJ, et al. Improving efficiency of pediatric emergency asthma treatment by using metered dose inhaler. J Asthma 2019; 56: 1079–1086.
8. Rodriguez-Martinez CE, Sossa-Briceño MP, Castro-Rodriguez JA. Metered-dose inhalers vs nebulization for the delivery of albuterol in pediatric asthma exacerbations: A cost-effectiveness analysis in a middle-income country. Pediatr Pulmonol 2020; 55: 866–873.
9. Iramain R, Castro-Rodriguez JA, Jara A, et al. Salbutamol and ipratropium by inhaler is superior to nebulizer in children with severe acute asthma exacerbation: Randomized clinical trial. Pediatr Pulmonol 2019; 54: 372–377.
10. Hamza MB. Spacers Versus Nebulizers in Treatment of Acute Asthma - A Prospective Randomized Study in Preschool Children. Egypt J Hosp Med 2022; 88: 2996.
11. Mittal K, Batra R, Khanna A. Comparison of effectiveness of metered dose inhaler with spacer and jet nebulizer in children aged 5–14 years with acute exacerbation of asthma: A pilot randomized controlled trial. J Pediatr Crit Care 2021; 8: 177.
12. Roncada C, Andrade J, Bischoff L carolina, et al. Comparison of two inhalational techniques for bronchodilator administration in children and adolescents with acute asthma crisis: A meta‑analysis. Rev Paul Pediatr 2018; 36: 364–371.
13. Dnp KD. Using A Metered Dose Inhaler ( Mdi ) With Spacer or Nebulizer for Managing Children Under 5 Years of Age with Exacerbation of Wheezing or Asthma. Epub ahead of print 2019. DOI: 10.19080/JOJNHC.2019.11.555815.
14. Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database of Systematic Reviews 2013, Issue 9. Art. No.: CD000052. DOI: 10.1002/14651858.CD000052.pub3.